CJ CheilJedang said on the 22nd that it signed a technology license agreement for lysine products with China's state-owned "Xinghuipin (StarLakeEppen)."
Through this partnership, CJ CheilJedang will grant Xinghuipin exclusive rights in China to use its lysine strains. The company said it plans to maximize synergy by combining CJ CheilJedang's differentiated lysine fermentation and strain process-optimization technology with Xinghuipin's large-scale production capacity and global market network.
Xinghuipin is a global biofermentation technology corporations that produces amino acids, food additives, and fertilizers. CJ CheilJedang is also expected to secure stable royalty revenue.
Yoon Seok-hwan, CEO of CJ CheilJedang, said at the signing ceremony, "The value of CJ CheilJedang's lysine technology and strains has once again been recognized in the global market," and "this collaboration goes beyond a simple technology license agreement and is meaningful in that the two companies have laid a solid foundation for sustainable growth in the amino acid industry."
The two companies plan to continue their cooperation in the fields of biotechnology and biofermentation technology going forward.
CJ CheilJedang expanded its green bio product portfolio by adding threonine in 2000 after starting with lysine in 1991, tryptophan in 2010, valine in 2014, and methionine in 2015. It currently holds the world's largest portfolio of eight feed amino acids.